Cargando…

A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis

PURPOSE: Activation of actin cytoskeleton remodeling is an important stage preceding cancer cell metastasis. Previous genome-wide association studies (GWAS) have identified multiple hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)-associated risk loci. However, limited sample size or s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mai, Haoming, Xie, Haisheng, Hou, Jia, Chen, Haitao, Zhou, Bin, Hou, Jinlin, Jiang, Deke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422165/
https://www.ncbi.nlm.nih.gov/pubmed/34513747
http://dx.doi.org/10.2147/JHC.S321939
_version_ 1783749234249433088
author Mai, Haoming
Xie, Haisheng
Hou, Jia
Chen, Haitao
Zhou, Bin
Hou, Jinlin
Jiang, Deke
author_facet Mai, Haoming
Xie, Haisheng
Hou, Jia
Chen, Haitao
Zhou, Bin
Hou, Jinlin
Jiang, Deke
author_sort Mai, Haoming
collection PubMed
description PURPOSE: Activation of actin cytoskeleton remodeling is an important stage preceding cancer cell metastasis. Previous genome-wide association studies (GWAS) have identified multiple hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)-associated risk loci. However, limited sample size or strict significance threshold of GWAS may cause HBV-related HCC risk-associated genetic loci to be undetected. We aimed to investigate the performance of the SNP rs13025377 in PPP1CB in HCC. PATIENTS AND METHODS: We performed a case–control study including 1161 cases and 1353 controls to evaluate associations between single nucleotide polymorphisms (SNPs) from 98 actin-cytoskeleton regulatory genes and risk of HBV-related HCC. The effects of SNPs on HBV-related HCC risk were assessed under logistic regression model and corrected by false discovery rate (FDR). RESULTS: We found that rs13025377 in PPP1CB was significantly associated with HBV-related HCC risk [odds ratio (OR) = 0.81, 95% confidence interval (CI) = 0.72~0.91, P = 4.88×10(–4)]. The risk allele A of rs13025377 increased PPP1CB expression levels in normal liver tissue. SNP rs4665434 was tagged by rs13025377 (r(2) = 0.9) and its protective allele disrupted CTCF and Cohesin motifs. According to public datasets, PPP1CB, CTCF and Cohesin expression levels are increased in tumor tissues. Kaplan–Meier plots demonstrated that higher PPP1CB expression was significantly associated with shorter overall survival (OS). Moreover, we observed strong correlation between CTCF, Cohesin, and PPP1CB in various liver tissues. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis confirmed that PPP1CB plays a role in HCC through actin-cytoskeleton regulation. CONCLUSION: Thus, these findings indicated that PPP1CB may be a key gene in actin-cytoskeleton regulation and rs13025377 contributes to the risk of HBV-related HCC by regulating PPP1CB expression.
format Online
Article
Text
id pubmed-8422165
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84221652021-09-09 A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis Mai, Haoming Xie, Haisheng Hou, Jia Chen, Haitao Zhou, Bin Hou, Jinlin Jiang, Deke J Hepatocell Carcinoma Original Research PURPOSE: Activation of actin cytoskeleton remodeling is an important stage preceding cancer cell metastasis. Previous genome-wide association studies (GWAS) have identified multiple hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)-associated risk loci. However, limited sample size or strict significance threshold of GWAS may cause HBV-related HCC risk-associated genetic loci to be undetected. We aimed to investigate the performance of the SNP rs13025377 in PPP1CB in HCC. PATIENTS AND METHODS: We performed a case–control study including 1161 cases and 1353 controls to evaluate associations between single nucleotide polymorphisms (SNPs) from 98 actin-cytoskeleton regulatory genes and risk of HBV-related HCC. The effects of SNPs on HBV-related HCC risk were assessed under logistic regression model and corrected by false discovery rate (FDR). RESULTS: We found that rs13025377 in PPP1CB was significantly associated with HBV-related HCC risk [odds ratio (OR) = 0.81, 95% confidence interval (CI) = 0.72~0.91, P = 4.88×10(–4)]. The risk allele A of rs13025377 increased PPP1CB expression levels in normal liver tissue. SNP rs4665434 was tagged by rs13025377 (r(2) = 0.9) and its protective allele disrupted CTCF and Cohesin motifs. According to public datasets, PPP1CB, CTCF and Cohesin expression levels are increased in tumor tissues. Kaplan–Meier plots demonstrated that higher PPP1CB expression was significantly associated with shorter overall survival (OS). Moreover, we observed strong correlation between CTCF, Cohesin, and PPP1CB in various liver tissues. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis confirmed that PPP1CB plays a role in HCC through actin-cytoskeleton regulation. CONCLUSION: Thus, these findings indicated that PPP1CB may be a key gene in actin-cytoskeleton regulation and rs13025377 contributes to the risk of HBV-related HCC by regulating PPP1CB expression. Dove 2021-09-02 /pmc/articles/PMC8422165/ /pubmed/34513747 http://dx.doi.org/10.2147/JHC.S321939 Text en © 2021 Mai et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mai, Haoming
Xie, Haisheng
Hou, Jia
Chen, Haitao
Zhou, Bin
Hou, Jinlin
Jiang, Deke
A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis
title A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis
title_full A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis
title_fullStr A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis
title_full_unstemmed A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis
title_short A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis
title_sort genetic variant of ppp1cb influences risk of hepatitis b virus-related hepatocellular carcinoma in han chinese: a pathway based analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422165/
https://www.ncbi.nlm.nih.gov/pubmed/34513747
http://dx.doi.org/10.2147/JHC.S321939
work_keys_str_mv AT maihaoming ageneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT xiehaisheng ageneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT houjia ageneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT chenhaitao ageneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT zhoubin ageneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT houjinlin ageneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT jiangdeke ageneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT maihaoming geneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT xiehaisheng geneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT houjia geneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT chenhaitao geneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT zhoubin geneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT houjinlin geneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis
AT jiangdeke geneticvariantofppp1cbinfluencesriskofhepatitisbvirusrelatedhepatocellularcarcinomainhanchineseapathwaybasedanalysis